Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Saltz, LB; Niedzwiecki, D; Hollis, D; Goldberg, RM; Hantel, A; Thomas, JP; Fields, ALA; Carver, G; Mayer, RJ

Published Date

  • July 15, 2004

Published In

Volume / Issue

  • 22 / 14

Start / End Page

  • 245S - 245S

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 40th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • New Orleans, LA

Conference Start Date

  • June 5, 2004

Conference End Date

  • June 8, 2004